Acutus Medical (Nasdaq:AFIB) shares took a hit today despite fourth-quarter results that came in ahead of the consensus forecast. Shares of AFIB fell 11% to 89¢ apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.8%. The Carlsbad, California-based arrhythmia management […]
Acutus Medical
Acutus Medical picks new CFO from within, announces 2023 guidance
Acutus Medical (Nasdaq:AFIB) announced today that it promoted Takeo Mukai to senior vice president and chief financial officer (CFO). Mukai joined Acutus in July 2021 as VP, finance. He expanded his responsibilities over the past 18 months, most recently serving as interim CFO. “Takeo has led our strategic priority to drive operational excellence at Acutus […]
The top 10 cardiac device stories of 2022
From pulsed-field ablation to noninvasive monitoring, this was an exciting year for cardiac device tech. Here are the top 10 cardiac device stories from MassDevice and its sister sites: 10. Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio Earlier this year, Acutus agreed to sell its left-heart access portfolio to […]
Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio
Acutus Medical (Nasdaq:AFIB) announced today that it achieved its second milestone under an asset purchase agreement with Medtronic (NYSE:MDT). The milestone covers submission for CE mark of the Acutus left-heart access portfolio under EU MDR. Hitting the milestone triggered a $17 million earnout payment from Medtronic to Acutus. Earlier this year, Acutus agreed to sell its left-heart […]
Acutus Medical fully launches next-gen heart ultrasound software
Acutus Medical (Nasdaq: AFIB) today announced the full commercial release of its next-gen AcQMap 8.5.
Acutus Medical (Nasdaq: AFIB) today announced the full commercial release of its next-gen AcQMap 8.5. Its latest heart ultrasound platform includes software improvements that further leverage the system’s capabilities for non-contact anatomy reconstruction, according to Carlsbad, California–based Acutus. “AcQMap 8.5 represents an important step forward in our technology roadmap with a specific focus on improving […]
Medtronic begins distributing Acutus AcQCross sheath-compatible septal crossing devices
Acutus Medical (Nasdaq:AFIB) announced today that Medtronic (NYSE:MDT) intends to begin distributing its left-heart access devices. In April, Acutus agreed to sell its left-heart access portfolio to Medtronic for $50 million. That portfolio includes the AcQCross line of sheath-compatible septal crossing devices. It also features the AcQGuide Mini, AcQGuide Flex and AcQGuide VUE technologies. Acutus […]
Acutus Medical faces Nasdaq delisting
Acutus Medical (Nasdaq:AFIB) announced that it received a letter from the Nasdaq stock market indicating unsatisfied listing requirements. The Carlsbad, California-based company said it received notification from Nasdaq that it has failed to maintain a minimum bid price of $1 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on […]
Acutus Medical achieves $20M milestone in Medtronic deal
Acutus Medical (Nasdaq:AFIB) announced today that it completed the first milestone under its asset purchase agreement with Medtronic (NYSE:MDT). Carlsbad, California-based Acutus announced in April that it agreed to sell its left-heart access portfolio to Medtronic for $50 million. It completed the first of two closings in its portfolio sale in June. The achievement of the first […]
Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
Acutus Medical (Nasdaq:AFIB) this week posted second-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Carlsbad, California-based company reported profits of $5.7 million, or 16¢ per share, on sales of $4.1 million for the three months ended June 30, for a bottom-line gain of 119.9% on sales loss of […]
Acutus Medical’s chief translational science officer is stepping down
Acutus Medical (Nasdaq:AFIB) Chief Translational Science Officer Dr. Steven Mickelsen recently announced he is stepping down to focus on patient care and new cardiac innovation. Mickelsen has been with the company for three years and led the design team to create a pulsed field ablation waveform to expand the capabilities of the company’s AcQblate contact-force ablation […]
The biggest medtech personnel moves so far in 2022
In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit. At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. So far in 2022, we’ve already seen a slew of major moves involving some of the space’s most powerful […]
